S6 Ep42: Jabbour Highlights New Data With Asciminib and Ponatinib in CML
OncLive® On Air
00:00
Mechanism and Class of Asciminib
Elias Jabbour explains how asciminib (STAMP class) binds the myristoyl pocket to inhibit BCR-ABL differently from ATP-site TKIs.
Play episode from 01:29
Transcript
